máculas melanóticas Mácula melanótica🤎 Síndrome de Laugier-Hunziker: reporte de
Description
CPT1 inhibition prevents the entry of FA into mitochondria and thus downstream FAO (65)
In a study conducted in 2008, differences between ALC-treated and placebo-treated patients for the following parameters were: muscle pain 27% versus 3% ( p = 0.02)
Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al
Retrieved 12 August 2010
